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Do level and variability of systolic blood pressure predict arterial
properties or vice versa?
Y-P Liu1, Y-M Gu1, L Thijs1, K Asayama1,2, Y Jin1, L Jacobs1, T Kuznetsova1, P Verhamme3, L Van Bortel4, HAJ Struijker-Boudier5 and
JA Staessen1,6
No longitudinal study addressed whether systolic blood pressure level (SBPL) or within-visit variability (SBPV) predict arterial
properties or vice versa. In families randomly recruited from a Flemish population, we determined SBPL and SBPV from five
consecutive blood pressure readings. The indexes of SBPV were variability independent of the mean, the difference between
maximum and minimum SBPL, and average real variability. We measured carotid intima-media thickness and distensibility by
ultrasound and carotid–femoral pulse wave velocity by tonometry (SphygmoCor, version 8.2). Effect sizes were computed for 1-s.d.
increments in the predictors, while accounting for covariables and family clusters. Among 1087 participants (50.4% women; mean
age, 41.8 years), followed up for 2.55 years (median), higher SBPL predicted (Pp0.019) higher carotid intima-media thickness
(þ 15mm), lower carotid distensibility ( 1.53 10 3 kPa 1) and faster carotid–femoral pulse wave velocity (þ 0.285m s 1) at
follow-up, whereas none of the SBPV indexes predicted the arterial traits at follow-up (PX0.11). In a subset of 713 participants,
followed up for another 3.14 years, lower carotid distensibility predicted (Po0.01) higher SBPL (þ 2.57mmHg), variability
independent of the mean (þ 0.531 units), difference between maximum and minimum SBPL (þ 1.75mmHg) and average real
variability (þ 0.654mmHg). Higher carotid–femoral pulse wave velocity predicted a 1.11mmHg increase SBPL (P¼ 0.031). In
conclusion, temporality and effect size suggest that SBPL but not within-visit SBPV cause arterial stiffness and carotid intima-media
thickness. Carotid stiffness, independent of SBPL, predicts within-visit SBPV, possibly because baroreflexes originating from a stiff
carotid artery wall are impaired. Finally, stiffness of the aorta contributes to the age-related SBPL possibly, because faster returning
reflected waves augments SBPL.
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INTRODUCTION
Central elastic arteries buffer systolic blood pressure during
ventricular ejection and through elastic recoil sustain diastolic
blood pressure to keep blood flowing during diastole.1 Each year,
the heart contracts over 30 million times to eject blood in the
arterial vasculature. With aging, these repetitive pulsations cause
fragmentation and fracture of the elastin fibers in the arterial wall,
so that the central elastic arteries stiffen and dilate. Arterial
stiffening makes the pulse wave reflected from peripheral sites in
the vasculature returning faster, thereby augmenting systolic
blood pressure.2 Consequently, with aging, systolic blood pressure
rises and diastolic blood pressure falls. Hypertension adds to the
cyclic stress and accelerates arterial aging. Stiffening of the central
arteries and systolic augmentation are keys to the pathogenesis of
isolated systolic hypertension in the elderly.3 Stiffer central arteries
also contribute to greater blood pressure variability, for instance in
response to exercise4 or the cold pressor test.5 Vice versa, greater
blood pressure variability with periods of episodic hypertension6
might promote arterial stiffening.
To our knowledge, few longitudinal studies7–13 investigated
whether blood pressure predicts arterial structure and function, of
which only two8,13 considered blood pressure variability as
potential prognosticator. Conversely, only one14 prospective
study explored whether arterial properties can predict blood
pressure. Therefore, the issue whether level and variability of
blood pressure predict arterial properties or vice versa, remains
largely unanswered. To research this question, we analyzed
a random population sample enrolled in the longitudinal
Flemish study on Environment Genes and Health Outcomes
(FLEMENGHO).15,16
MATERIALS AND METHODS
Study population
As described in detail in the on-line only data Supplementary Material,
recruitment for the FLEMENGHO study started in 1985.16,17 The Ethics
Committee of the University of Leuven approved the study. All participants
or their parents gave informed written consent. The participants were
repeatedly followed up. In all study phases, we used the same
standardized methods to measure blood pressure and to administer
questionnaires. From January 1992 until December 2007,18,19 we re-invited
1858 participants for a follow-up examination that included arterial
phenotyping. Of those invited 1379 took part in the examinations
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(participation rate, 74.2%). We excluded 86 subjects who were younger
than 18 years old.
For the purpose of the current analysis, we defined two cohorts (Figure 1
and Supplementary Figure S1): (i) the BP-ART cohort consisting of
participants followed from enrollment until arterial phenotyping; (ii) and
the ART-BP cohort consisting of participants who had at least one
assessment of their blood pressure after arterial phenotyping. From the
BP-ART cohort, we excluded 206 subject because they had incomplete
arterial phenotypes without measurement of carotid intima-media
thickness (n¼ 141), carotid distensibility (n¼ 68), or carotid–femoral pulse
wave velocity (n¼ 93). Thus, the number of participants analyzed to
predict arterial properties from blood pressure totaled 1087. These 1087
participants were eligible for inclusion in the ART-BP cohort. However, at
the time of writing of this manuscript 374 did not yet have a follow-up
measurement of their blood pressure. Thus, the number of participants in
the ART-BP cohort analyzed to predict blood pressure from arterial
properties totaled 713.
Blood pressure measurement
At enrollment and follow-up, trained nurses measured each participant’s
blood pressure at a home visit. After the participants had rested for 5min
in the sitting position, the nurses obtained five consecutive blood pressure
readings to the nearest 2mmHg at an interval of approximately 1min,
using standard mercury sphygmomanometers. Standard cuffs had a
12 24 cm inflatable portion, but if upper arm girth exceeded 31 cm,
larger cuffs with 15 35 cm bladders were used. As described in the
Expanded Methods, available online, we implemented a stringent program
for quality assurance and quality control of the blood pressure
measurements. Hypertension was a blood pressure (average of five
readings) of at least 140mmHg systolic or 90mmHg diastolic or use of
antihypertensive drugs.
Arterial phenotyping
The on-line only data Supplementary Material provides a detailed
description of the methods used for arterial phenotyping. One trained
nurse measured carotid–femoral pulse wave velocity by applanation
tonometry at the carotid and femoral artery, using a high-fidelity SPC-301
micromanometer (Millar Instruments, Houston, TX, USA) interfaced with a
laptop computer running the SphygmoCor software, version 8.2 (AtCor
Medical Pty., West Ryde, NSW, Australia).
Three highly skilled researchers used a pulsed ultrasound wall-tracking
system (Wall Track System; Pie Medical, Maastricht, The Netherlands) to
measure carotid distensibility and intima-media thickness at the common
carotid artery 2 cm proximal of the carotid bulb. During the procedure an
automated oscillometric device (Dinamap 845, Critikon, Tampa, FL, USA)
recorded blood pressure at the upper arm at 5-minute intervals. The
researchers used applanation tonometry with a pencil-shaped probe
(Millar Instruments) and calibration to mean arterial pressure and diastolic
blood pressure at the brachial artery to derive the local pulse pressure at
the carotid artery.20 The carotid distensibility coefficient was derived from
the diastolic cross-sectional area, the systolic increase in cross-sectional
area, and the local pulse pressure.18 The observers also measured, the
distances from the adventitia-media boundary of the near wall to the
lumen-intima and media-adventitia interfaces of the far wall. Carotid
intima-media thickness was the mean difference between these distances.
The carotid measurements were obtained over three separate intervals of
5.2 s, which on average included 15 heart cycles.19
Other measurements
At each contact, the nurses administered the same questionnaire to collect
information about the participants’ medical history, smoking and drinking
habits, and intake of medications. Body mass index was body weight in
kilogram divided by body height in meter squared. Venous blood samples
were drawn for measurement of serum total cholesterol and blood
glucose. Diabetes was the use of antidiabetic drugs, a fasting blood
glucose concentration of at least 7.0mmol l 1,21 a random blood glucose
concentration of at least 11.1mmol l 1,21 a self-reported diagnosis, or
diabetes documented in practice or hospital records.
Statistical analysis
For database management and statistical analysis, we used SAS software
(SAS Institute, Cary, NC, USA), version 9.3. We compared means and
proportions, using a large sample z test, and w2 statistic, respectively. We
searched for possible covariables of blood pressure and the arterial traits,
using a stepwise regression procedure with P-values for independent
variables to enter and stay in the model set at 0.15. We used mixed models
to study the association between the outcome and predictor variables,
while adjusting for baseline characteristics, including sex, age, body mass
index, heart rate, smoking and drinking, intake of female sex hormones,
non-steroidal anti-inflammatory drugs and antihypertensive drugs, serum
cholesterol and blood glucose, and follow-up duration. A sensitivity
analysis additionally accounted for family clusters modeled as a random
effect. In the analysis of the BP-ART cohort, we adjusted blood pressure
for the indexes of blood pressure variability and vice versa. We confined
our analyses to systolic blood pressure, because it is the distending force in
arteries and because it is the predominant cardiovascular risk factor. We
assessed within-visit blood pressure variability from the variability
independent of the mean,22 the difference between the maximum
minus minimum blood pressure, and average real variability.23 Formulas
for the derivation of these indexes appear in the on-line only data
Supplementary Material.
RESULTS
Analyses of the BP-ART cohort
Baseline characteristics. The 1087 participants included 548
women (50.4%). Mean (±s.d.) age was 41.8±13.6 years
(Table 1). At enrollment, 375 participants (34.5%) were smokers,
300 (27.6%) reported intake of alcohol, 243 (22.4%) and 34 (3.1%)
had hypertension or diabetes mellitus, respectively. Of the 1087
participants, 96 (8.8%) were on antihypertensive drug treatment
and 86 (7.9%) took non-steroidal anti-inflammatory drugs. Among
women, 138 (25.2%) used contraconceptive pills (n¼ 128) or
hormonal replacement therapy (n¼ 10). Compared with women
(Table 1), men more frequently (Po0.001) reported drinking
alcohol (13.7 vs 41.7%) and had higher body mass index (24.7 vs
25.6 kgm 2). As shown in Table 2, women had a higher heart rate
than men had (70.7 vs 67.4 beats per minute), but lower systolic
and diastolic blood pressures (120.3/75.2 vs 127.0/78.5mmHg).
The indexes of systolic blood pressure variability were similar in
women and men (PX0.05).
Arterial properties at follow-up. Median follow-up was 2.55 years
(interquartile range (IQR), 2.05–6.51 years). Women had higher
carotid distensibility (25.2 vs 23.3 10 3 kPa 1) than men did, but
carotid intima-media thickness and carotid–femoral pulse wave
velocity were similar in both sexes (Table 2). The baseline
determinants of one or more of the arterial properties traits
under study were sex, age, body mass index, heart rate, drinking
alcohol, antihypertensive drug treatment, serum cholesterol and
Figure 1. Timelines of the BP-ART and ART-BP substudies.
BP-ART cohort and ART-BP cohort refer to participants analyzed
to predict arterial properties at follow-up from blood pressure at
baseline or participants analyzed to predict blood pressure at
follow-up from arterial properties at baseline. Median follow-up in
the BP-ART cohort was 2.55 years (interquartile range: 2.05–6.51
years, and range: 0.60–14.8 years), and 3.14 years (1.91–6.22 and
0.82–11.7 years) in the ART-BP cohort. SBPL, systolic blood pressure
level; SBPV, systolic blood pressure variability; cIMT, carotid intima-
media thickness; cDC, carotid distensibility coefficient; cfPWV,
carotid–femoral pulse wave velocity.
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blood glucose (Supplementary Table S1). These covariables
explained 30.2, 51.4, and 28.4% of the variation in carotid
intima-media thickness, carotid distensibility, and carotid–
femoral pulse wave velocity.
Prediction of the arterial properties at follow-up from systolic
pressure at baseline. In analyses adjusted for the covariables
listed in Supplementary Table S1, a 15-mmHg (B1 s.d.) increase in
systolic blood pressure at baseline was associated with a 15.5 mm
(P¼ 0.019) increase in carotid intima-media thickness, with a 1.53
10 3 kPa 1 (Po0.001) decrease in carotid distensibility and with
a 0.285m s 1(Po0.001) faster carotid–femoral pulse wave velo-
city (Table 3). Adjustment for variability independent of the mean,
the difference between maximum and minimum pressure or
average real variability did not alter these results (Table 3). None of
the indexes of systolic blood pressure variability predicted the
arterial traits at follow-up (PX0.11; Table 3). Accounting for family
cluster did not materially change these findings (Supplementary
Table S3). We did the sensitivity analysis, which included the
subjects (n¼ 713) who were also in the ART-BP cohort. As shown
in Supplementary Table S5, the association between blood
pressure measurement at baseline and arterial phenotypes at
follow-up remained consistent.
Analyses of the ART-BP cohort
Baseline characteristics. The 713 participants included 357
women (50.1%). Mean (±s.d.) age was 46.3±13.7 years
Table 1. Characteristics of participants at baseline and follow-up by cohort and sex
Characteristic BP-ART cohort ART-BP cohort
Women Men All Women Men All
Number of subjects 548 539 1087 357 356 713
Median follow-up (IQR) 2.52 (2.06–6.52) 2.56 (2.03–6.50) 2.55 (2.05–6.51) 3.14 (1.92–6.69) 3.14 (1.89–5.63) 3.14 (1.91–6.22)
Number (%) with characteristic
Smoking 174 (31.7) 201 (37.3) 375 (34.5) 104 (29.1) 124 (34.8) 228 (32.0)
Drinking 75 (13.7) 225 (41.7)z 300 (27.6) 84 (23.5) 197 (55.3)z 281 (39.4)
Hypertension 106 (19.3) 137 (25.4)* 243 (22.4) 119 (33.3) 156 (43.8)w 275 (38.6)
Antihypertensive treatment 58 (10.6) 38 (7.0) 96 (8.8) 58 (16.2) 46 (12.9) 104 (14.6)
Use of female hormones 138 (25.2) — 138 (12.7) 37 (10.4) — 37 (5.2)
Use of NSAID 44 (8.0) 42 (7.8) 86 (7.9) 26 (7.3) 27 (7.6) 53 (7.4)
Diabetes mellitus 18 (3.3) 16 (3.0) 34 (3.1) 13 (3.6) 8 (2.2) 21 (2.9)
Mean (±s.d.) characteristic
Age, years 42.0±13.6 41.6±13.5 41.8±13.6 46.7±13.4 45.9±14.0 46.3±13.7
Body mass index, kgm 2 24.7±4.3 25.6±3.4z 25.2±3.9 25.3±4.4 25.7±3.5 25.5±3.9
Total cholesterol, mmol l 1 5.53±1.15 5.53±1.23 5.53±1.19 5.61±1.02 5.58±1.10 5.60±1.06
Blood glucose, mmol l 1 4.76±1.05 4.83±1.12 4.79±1.08 4.81±0.99 4.89±1.06 4.85±1.02
Abbreviations: IQR, interquartile range; NSAID, non-steroidal anti-inflammatory drugs. BP-ART cohort and BP-ART cohort refer to participants analyzed to
predict arterial properties from systolic blood pressure or participants analyzed to predict systolic blood pressure from arterial properties. To convert
cholesterol and glucose from mmol l 1 to mgdl 1, multiply by 38.6 and 18.0, respectively. Significance of the sex difference: *Po0.05; wPo0.01; zPo0.001.
Table 2. Blood pressure and arterial properties at baseline and follow-up by cohort and sex
Characteristic BP-ART cohort ART-BP cohort
Women Men All Women Men All
Number of subjects 548 539 1087 357 356 713
Blood pressure Baseline Follow-up
Diastolic pressure, mmHg 75.2±19.7 78.5±10.1z 76.9±10.0 75.3±9.3 77.8±9.9z 76.5±9.7
Systolic pressure
Level, mmHg 120.3±14.5 127.0±13.6z 123.6±14.5 123.7±17.1 126.0±14.1* 124.8±15.7
VIM, units 3.21±1.98 3.18±1.98 3.19±1.98 3.64±1.85 3.43±1.85 3.54±1.85
MMD, mmHg 7.49±5.10 8.09±5.50 7.79±5.31 8.83±5.02 8.55±5.27 8.69±5.15
ARV, mmHg 3.19±2.22 3.36±2.19 3.27±2.21 3.62±1.90 3.74±2.27 3.68±2.09
Heart rate, beats per minute 70.7±9.2 67.4±9.7z 69.1±9.6 67.4±7.7 65.6±8.7z 66.5±8.3
Arterial properties Follow-up Baseline
Carotid IMT, mm 687.3±214.0 703.7±240.0 695.4±227.3 706.1±214.2 723.6±248.6 714.8±232.0
Carotid distensibility, 10 3 kPa 1 25.2±12.6 23.3±10.1z 24.2±11.5 24.1±11.3 23.3±10.0 23.7±10.7
Carotid–femoral PWV, m s 1 6.52±2.07 6.68±2.10 6.60±2.08 6.51±1.99 6.67±2.14 6.59±2.06
Abbreviations: ARV, average real variability; IMT, intima-media thickness; MMD; difference of maximum minus minimum blood pressure; VIM, variability
independent of the mean. BP-ART cohort and BP-ART cohort refer to participants analyzed to predict arterial properties from systolic blood pressure or
participants analyzed to predict systolic blood pressure from arterial properties. Plus–minus values are mean±s.d. Blood pressure was the average of five
consecutive readings at a single visit. Significance of the sex difference: *Po0.05; zPo0.001.
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(Table 1). At baseline, 228 participants (32.0%) were smokers, 281
(39.4%) reported intake of alcohol, 275 (38.6%) and 21 (2.9%) had
hypertension or diabetes mellitus, respectively. Of the 713
participants, 104 (14.6%) were on antihypertensive drug treatment
and 53 (7.4%) took non-steroidal anti-inflammatory drugs. Among
women, 37 (10.4%) used contraconceptive pills (n¼ 30) or
hormonal replacement therapy (n¼ 7). Compared with women
(Table 1), men more frequently reported drinking alcohol (55.3 vs
23.5%). As shown in Table 2, the arterial properties at baseline
were similar in women and men (PX0.09).
Blood pressure at follow-up. Median follow-up was 3.14 years
(IQR, 1.91–6.22 years). At follow-up, women had a higher heart
rate than men did (67.4 vs 65.6 beats per minute), but lower
systolic and diastolic blood pressures (123.7/75.3 vs 126.0/
77.8mmHg). The indexes of systolic blood pressure variability
were similar in women and men (PX0.13). The baseline
determinants of level and variability of systolic blood pressure at
follow-up included age, systolic blood pressure measured at the
time of arterial phenotyping, body mass index, smoking, drinking,
use of antihypertensive drugs, and blood glucose (Supplementary
Table S2). These covariables explained 44.5, 2.6, 6.7, and 5.6% of
the variation at follow-up in systolic blood pressure level,
variability independent of the mean, maximum–minimum differ-
ence and average real variability, respectively.
Prediction of systolic pressure at follow-up from arterial properties at
baseline. In models adjusted for the covariables listed in
Supplementary Table S2, carotid distensibility was consistently
and inversely associated with the level and variability of systolic
blood pressure at follow-up (Table 4 and Figure 2). The effect sizes
associated with a 1-s.d. decrease in carotid distensibility (B13
10 3 kPa 1) were þ 2.57mmHg for systolic blood pressure level
(P¼ 0.004), þ 0.531 units for variability independent of the mean
(P¼ 0.001), þ 1.75mmHg for the maximum–minimum systolic
difference (Po0.001), and þ 0.654mmHg for average real
variability (Po0.001). A 1-s.d. increase in carotid–femoral pulse
wave velocity (B2m s 1) predicted a 1.11mmHg increase in
systolic blood pressure at follow-up (P¼ 0.031). Accounting for
family clusters revealed a consistent association of carotid intima-
media thickness with all indexes of blood pressure variability
(Supplementary Table S4). The effect sizes associated with a 1-s.d.
increase in carotid intima-media thickness were þ 0.166 units for
variability independent of the mean (P¼ 0.048), þ 0.527mmHg
for the maximum–minimum difference (P¼ 0.026), and 0.179mm
Hg for average real variability (P¼ 0.042).
Comparison between participants returning or not for arterial
phenotyping
Among the 3284 subjects who were initially enrolled, 1379
attended the examination including arterial phenotyping and
1905 did not have these measurements. Compared with
participants undergoing arterial phenotyping, those who did
more frequently reported smoking or drinking alcohol
(Supplementary Table S6). The participants with arterial pheno-
types were also older, had higher serum cholesterol, systolic
pressure, average real variability and lower heart rate
(Supplementary Table S6).
DISCUSSION
No longitudinal study addressed whether systolic blood pressure
level or variability predict arterial properties or vice versa. The key
findings of our study were (i) that level, but not within-visit
variability of systolic blood pressure predicted arterial stiffness of
the central elastic arteries and carotid intima-media thickness;
(ii) that carotid stiffness, independent of the level of blood
pressure, predicted within-visit systolic blood pressure variability;
and (iii) that stiffness of the aorta contributes to the age-related
increase in systolic blood pressure.
Three previous studies in hypertensive patients9,13 or patients
referred to exclude neurologic disorders8 included from
286–2785 participants followed up on average for 3.38 to 6.09
years. In line with our current findings, these studies reported
that blood pressure as continuous variable8,9,13 or hypertension9
on conventional9,13 or ambulatory8,13 measurement predicted
thickening of the carotid-intima media8,13 or an increase in aortic
pulse wave velocity.9 Four population studies,7,10–12 of which
two were confined to men,7,11 enrolled young adults,10 middle-
aged participants,7,11 or elderly12 followed up for periods
ranging from 4.07–20.011 years. In keeping with our current
observations, they showed in multivariable-adjusted analyses
that the conventionally measured blood pressure analyzed on a
continuous7,10–12 or categorical7 scale predicted increases in
carotid intima-media thickness,7,12 in the brachial-ankle10 or
aortic11 pulse wave velocity, or in the central augmentation
index.11
Table 3. Association of arterial phenotypes at follow-up with systolic predictors in the BP-ART cohort
Predictor variable (approximate s.d.) Model Carotid intima-media
thickness (mm)
Carotid distensibility
(10 3 kPa 1)
Carotid–femoral pulse wave
velocity (m s 1)
Systolic pressure (þ 15mmHg) y 15.5 (2.56 to 28.5)*  1.53 ( 2.09 to  0.971)z 0.285 (0.160 to 0.411)z
VIM 15.1 (2.17 to 28.1)*  1.51 ( 2.07 to  0.956)z 0.287 (0.161 to 0.413)z
MMD 17.1 (3.85 to 30.4)*  1.54 ( 2.12 to  0.966)z 0.276 (0.147 to 0.403)z
ARV 16.9 (3.76 to 30.1)*  1.49 ( 2.07 to  0.917)z 0.277 (0.151 to 0.404)z
Variability independent of the y  8.26 ( 19.1 to 2.64) 0.205 ( 0.277 to 0.687) 0.015 ( 0.092 to 0.123)
mean (þ 2 units) SBP  7.73 ( 18.6 to 3.17) 0.152 ( 0.326 to 0.630) 0.015 ( 0.091 to 0.122)
Difference of maximum minus minimum
systolic pressure (þ 5mmHg)
y  3.28 ( 13.6 to 7.03)  0.176 ( 0.632 to 0.280) 0.083 ( 0.019 to 0.184)
SBP  6.09 ( 16.6 to 4.42) 0.078 ( 0.382 to 0.539) 0.036 ( 0.066 to 0.139)
Average real variability (þ 2mmHg) y  4.18 ( 14.0 to 5.68)  0.358 ( 0.793 to 0.077) 0.070 ( 0.027 to 0.168)
SBP  6.34 ( 16.3 to 3.63)  0.168 ( 0.603 to 0.267) 0.034 ( 0.063 to 0.132)
Abbreviations: ARV, average real variability; MMD, the difference of maximum minus minimum systolic blood pressure; SBP, level of systolic pressure; VIM,
variability independent of the mean. Model indicates which systolic index was entered into the models in addition to the predictor variable per se: y, no
additional systolic index entered. Effect sizes (95% confidence interval) express the change in the arterial properties associated with a 1-s.d. increase in the
systolic predictor. All models were adjusted for the covariables listed in Supplementary Table S2. Significance of the estimates: *Po0.05; zPo0.001.
Arterial properties and blood pressure
Y-P Liu et al
4
Journal of Human Hypertension (2013) 1 – 7 & 2013 Macmillan Publishers Limited
In our present study, within-visit blood pressure variability at
baseline did not predict the arterial properties at follow-up. Only
two other prospective studies8,13 investigated whether blood
pressure variability can influence arterial structure. Both studies8,13
included selected patients rather than an unbiased population
sample and confined their outcome analysis to carotid intima-
media thickness. In the European Lacidipine Study on
Atherosclerosis (ELSA), visit-to-visit blood pressure variability did
not predict carotid intima-media thickness assessed 4 years after
enrollment.13 In contrast, Sander et al.,8 reported that in
multivariable-adjusted regression analyses daytime systolic
blood pressure variability was the best predictor of progression
of carotid intima-media thickness. The two studies had limitations.
Both8,13 applied measures of blood pressure variability that were
not independent of the level, such as the s.d.8,13 or coefficient of
variability.13 In ELSA,13 all patients were on antihypertensive drug
treatment. In Sander’s study,8 patients were referred for the
exclusion of neurologic disease, but the authors did not report the
prevalence or nature of neurologic abnormalities.
Several cross-sectional studies24–30 addressed the association of
blood pressure variability with arterial properties, including carotid
intima-media thickness,25,29 carotid stiffness27 or distension,24
or carotid–femoral pulse wave velocity.26,28 Blood pressure
variability was assessed from 24 h,24–26,28,29 daytime25,28,29 or
nighttime25,28,29 recordings, or from as within-30 or between-27
visit blood pressure variability. In general, these studies had
limitations, for instance by including a majority of patients on
antihypertensive drug treatment,27 by being confined to diabetic
patients,30 or by being confounded by dyslipidemia.29 They
produced contradictory results reporting presence25,27,28,30 or
absence24,26,29 of association between arterial properties and
blood pressure variability. Moreover, the cross-sectional design
makes inference of temporality or causality difficult.
In our current study, carotid stiffening predicted within-visit
systolic blood pressure variability independent of the level. Only
one previous study addressed the question whether the proper-
ties of the carotid artery can predict blood pressure variability.
Sander et al.,8 enrolled 286 of 424 patients referred to rule out
neurologic disease.8 Mean age at enrollment was 68 years. Blood
pressure variability was assessed from the within-patient s.d. of
the daytime ambulatory blood pressure, a measure of variability
that is dependent on the level. Using an arbitrary cut-off point for
the s.d. capturing blood pressure variability (15mmHg), these
researchers reported that there was no association between
carotid intima-media thickness at baseline and change in blood
pressure variability 3.3 years later. As mentioned previously,
another issue unaddressed in Sander’s report is the prevalence of
brain neurologic disease in the cohort, which might have had an
impact on blood pressure variability.
To explain the association between carotid stiffening and
increased blood pressure variability, we hypothesized that this
condition might affect afferent nerve traffic from the carotid body
Table 4. Association of systolic indexes at follow-up with arterial predictors in ART-BP cohort
Predictor variable
(approximate s.d.)
Systolic pressure
(mmHg)
Variability independent
of the mean (unit)
Difference of maximum
minus minimum pressure
(mmHg)
Average real variability
(mmHg)
Carotid intima-
media thickness
(þ 230mm)
0.729 ( 0.375 to 1.83) 0.120 ( 0.051 to 0.292) 0.414 ( 0.050 to 0.877) 0.136 ( 0.054 to 0.326)
Carotid
distensibility
( þ 13
10 3 kPa 1)
 2.57 ( 4.30 to  0.836)w  0.531 ( 0.800 to  0.263)z  1.75 ( 2.47 to  1.03)z  0.654 ( 0.951 to  0.357)z
Carotid–femoral
pulse wave
velocity
(þ 2ms 1)
1.11 (0.104 to 2.11)*  0.139 ( 0.296 to 0.017)  0.185 ( 0.608 to 0.238)  0.094 ( 0.268 to 0.079)
Effect sizes (95% confidence interval) express the systolic indexes associated with a 1-s.d. increase in the arterial predictor. All models were adjusted for the
covariables listed in Supplementary Table S2. Significance of the estimates: *Po0.05; wPo0.01; zPo0.001.
Figure 2. Associations between carotid distensibility at baseline and the indexes of systolic blood pressure variability at follow-up in the ART-
BP cohort. The regression lines were standardized to the distributions of the covariables listed in Supplementary Table S2 (mean or ratio for
continuous and categorical covariables, respectively). ARV, average real variability; MMD, difference of maximum minus minimum pressure;
SBP, systolic blood pressure; VIM, variability independent of the mean.
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to the brain, thereby impairing the baroreflexes. In a study of 47
untreated normotensive men, Mohan et al.,31 observed that carotid
arterial compliance was a strong determinant of baroreflex
sensitivity, explaining 51% of the total variance. Similarly, two
other studies involving younger32 or older33 healthy volunteers
reported an inverse association between indexes of carotid
stiffening and baroreflex sensitivity. Finally, Mattace-Raso et al.,34
showed a positive association between carotid distensibility and
baroreflex sensitivity in 2400 subjects aged 55 years or older
enrolled in the population-based Rotterdam study.
The third key finding in our study was that stiffening of the
elastic arteries contributed to the increase in systolic blood
pressure over time. The Framingham investigators examined in
1759 people (mean age, 60 years) followed up for 7 years, the
temporal relations among blood pressure and tonometrically
derived indexes of arterial stiffness.14 Higher values of carotid–
femoral pulse wave velocity, the forward wave amplitude, and the
augmentation index were all associated with higher blood
pressure and greater risk of incident hypertension.14 However, in
contrast to our current findings, initial blood pressure was not
independently associated with risk of progressive aortic
stiffening.14 The Atherosclerosis Risk in Communities (ARIC)
study investigators recruited 6992 normotensive women and
men from Black and White communities, aged 45–64 years at
baseline.35 Over 6 years of follow-up, there was a prospective
association between carotid stiffness, as reflected by Peterson’s
elastic modulus and b-stiffness index, and the development of
hypertension.35
Our study must be interpreted within the context of its
potential limitations. First, we assessed blood pressure variability
from five consecutive within-visit blood pressure readings.
However, in contrast to previous studies, we reported on the
quality assurance and control of the blood pressure phenotype.
We also used measures of variability that are independent of the
blood pressure level. Second, we measured blood pressure at
baseline and twice during follow-up, but we measured arterial
properties only once. Baseline is the main determinant of any
physiologic variable re-measured later during follow-up. We
adjusted blood pressure during follow-up for baseline in the
ART-BP analysis, but could not do this for the arterial properties
in the BP-ART cohort. However, adjustment for baseline arterial
properties can only weaken the association between blood
pressure variability at baseline and arterial characteristics at
follow-up. Even without this adjustment, blood pressure varia-
bility did not predict arterial properties. Third, we measured
within-visit blood pressure variability, which according to
some,36,37 but not all,6 publications might be a weaker
predictor than visit-to-visit variability and have lower
reproducibility. However, in the blood pressure lowering arm of
the Anglo-Scandinavian Cardiac Outcomes Trials,6 the intraclass
correlation coefficient (visits at 6–36 vs 42–72 months) was 0.30
(95% confidence interval, 0.27–0.33) for visit-to-visit variability
and 0.43 (0.40–0.45) for within-visit variability and within-visit
variability as captured by s.d. predicted stroke (hazard ratio for
top vs bottom decile adjusted for level of systolic blood pressure,
1.52; 95% confidence interval, 1.09–2.13). Notwithstanding these
findings,6 our current findings are based on within-visit variability
and cannot be extrapolated to visit-to-visit variability.
In conclusion, temporality and effect size in our current study
suggest that level of systolic blood pressure, but not within-visit
variability predicted arterial stiffness and thickness of the carotid
intima media. Furthermore, carotid stiffness, independent of the
level of systolic blood pressure, predicted within-visit systolic
blood pressure variability, most likely because baroreflexes
originating from a stiff carotid artery wall are impaired. Finally,
stiffness of the aorta contributes to the age-related rise in systolic
blood pressure, possibly because a faster return of the reflected
wave augments systolic blood pressure.
What is known about topic
 Few longitudinal studies investigated whether blood pressure
predicts arterial structure and function, of which only two considered
blood pressure variability as potential prognosticator.
 Daytime systolic blood pressure s.d. was the best predictor for
progression of carotid intima-media thickness in patients who were
referred for the exclusion of neurologic disease.
 In the European Lacidipine Study on Atherosclerosis (ELSA), visit-to-
visit blood pressure s.d. or coefficient of variability did not predict
carotid intima-media thickness assessed 4 years after enrollment.
 The Framingham investigators found that baseline arterial properties
predicted future blood pressure, while initial blood pressure was not
independently associated with risk of progressive aortic stiffening.
What this study adds
 This prospective population study is the first to investigate whether
level or variability of blood pressure predicts arterial properties or vice
versa
 We used measures of variability that are independent of the blood
pressure level
 Level of systolic blood pressure, but not variability predicts arterial
stiffness and thickness of the carotid intima media.
 Carotid stiffness, independent of the level of systolic blood pressure,
predicts systolic blood pressure variability, most likely because
baroreflexes originating from a stiff carotid artery wall are impaired.
 Stiffness of the aorta contributes to the age-related rise in systolic
blood pressure possibly because a faster return of the reflected wave
augments systolic blood pressure
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SUPPLEMENTAL MATERIAL  
This Data Supplement has been provided by the authors to give readers additional 
information about their work.  
Supplement to:  
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Bortel L, Struijker-Boudier HAJ, Staessen JA.  Do Level and Variability of Systolic Blood 
Pressure Predict Arterial Properties or Vice Versa?   J Hum Hypertens 2013 ...   
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Expanded Methods  
Study population  
Recruitment for the FLEMENGHO study started in 1985.1,2  From August 1985 to November 
1990, a random sample of the households living in a geographically defined area of Northern 
Belgium was investigated with the goal to recruit an equal number of participants in each of 6 
strata by sex and age (20-39, 40-59, and ≥60 years).  All household members aged 20 years 
or older were invited, if the quota of their sex-age group had not yet been satisfied.  From 
June 1996 until January 2007, recruitment of families continued using the former participants 
(1985-1990) as index persons and including teenagers.  At enrolment, the participation rate 
was 65.0%.  The Ethics Committee of the University of Leuven approved the study.  All 
participants or their parents gave informed written consent.   
The participants were repeatedly followed up.  In all study phases, we used the same 
standardized methods to measure blood pressure and to administer questionnaires.  From 
January 1992 until December 2007,3,4 we re-invited 1858 former participants for a follow-up 
examination that included arterial phenotyping.  Of those invited 1379 renewed consent and 
took part in the examinations.  The participation rate was 74.2%.  We excluded 86 
youngsters aged less than 18 years from analysis.   
For the purpose of the current analysis, we defined two cohorts (Figure 1 and S1) : (i) the 
BPART cohort consisting of participants followed from enrolment until arterial phenotyping; 
(ii) and the ARTBP cohort consisting of participants who had at least one assessment of 
their blood pressure after arterial phenotyping.  From the BPART cohort, we excluded 206 
subject because they had incomplete arterial phenotypes without measurement of carotid 
intima-media thickness (n=141), carotid distensibility (n=68) or carotid-femoral pulse wave 
velocity (n=93).  Thus, the number of participants analyzed to predict arterial properties from 
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blood pressure totaled 1087.  These 1087 participants were eligible for inclusion in the 
ARTBP cohort.  However, at the time of writing of this manuscript 374 did not yet have a 
follow-up measurement of their blood pressure.  Thus, the number of participants in the 
ARTBP cohort analyzed to predict blood pressure from arterial properties totaled 713.    
Blood pressure measurement  
At enrolment and follow-up, trained nurses measured each participant’s blood pressure at 
home visit.  After the participants had rested for 5 minutes in the sitting position, the nurses 
obtained five consecutive blood pressure readings to the nearest 2 mm Hg at an interval of 
approximately 1 minute, using a standard mercury sphygmomanometer.  Standard cuffs had 
a 12  24 cm inflatable portion, but if upper arm girth exceeded 31 cm, larger cuffs with 15  
35 cm bladders were used.  We implemented a stringent program for quality assurance and 
quality control of the blood pressure measurements.5,6  Every 3 months, the observers had 
to pass a test requiring them to read blood pressures from a videotape featuring a falling 
mercury column with Korotkoff sounds (Blood Pressure Measurement, British Medical 
Association, London, UK). Their readings had to comply within 5 mm Hg of those of senior 
medical staff.  Digit preference was checked at 6-month intervals.  Hypertension was a blood 
pressure (average of 5 readings) of at least 140 mm Hg systolic or 90 mm Hg diastolic or use 
of antihypertensive drugs.   
Arterial phenotyping  
For at least 3 hours before the examination, the participants were asked to refrain from 
heavy exercise, smoking, and intake of alcohol and caffeine-containing beverages.   
Carotid-femoral pulse wave velocity—After participants had rested in the supine position 
for at least 15 minutes, one trained nurse recorded, during an 8-s period, the carotid and 
femoral arterial waveforms at the right side by applanation tonometry.  She used a high-
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fidelity SPC-301 micromanometer (Millar Instruments Inc., Houston, TX) interfaced with a 
laptop computer running the SphygmoCor software, version 8.2 (AtCor Medical Pty., West 
Ryde, New South Wales, Australia).  Using a measuring tape, the nurse determined the 
distance from the suprasternal notch to the carotid sampling site (distance A) and the 
distance from the suprasternal notch to the femoral sampling site (distance B).  Pulse wave 
travel distance was (distance B minus distance A)  1.12.7  Pulse transit time was derived as 
the average of 10 consecutive beats.  Carotid-femoral pulse wave velocity was the ratio of 
the travel distance in meters to transit time in seconds.   
Carotid distensibility and intima-media thickness—Three highly skilled researchers used a 
pulsed ultrasound wall-tracking system (Wall Track System; Pie Medical, Maastricht, 
Netherlands) to obtained arterial measurements at the common carotid artery 2 cm proximal 
of the carotid bulb.  During the procedure an automated oscillometric device (Dinamap 845, 
Critikon Inc., Tampa, FL) recorded blood pressure at the upper arm at 5-minute intervals.  
The researchers used applanation tonometry with a pencil-shaped probe (Millar Instruments 
Inc.) and calibration to mean arterial pressure and diastolic blood pressure at the brachial 
artery to derive the local pulse pressure at the carotid artery.8  They determined the carotid 
distensibility coefficient (DC) from the diastolic cross-sectional area (A), the systolic increase 
in cross-sectional area (ΔA), and the local pulse pressure (PP): DC = (ΔA/A)/PP.  A and ΔA 
were calculated from diameter (D) and the change in diameter (ΔD) as A = π  (D/2)2 and 
ΔA = [(D + ΔD)/2]2 – D/2)2, respectively.3  The observers also measured, the distances from 
the adventitia-media boundary of the near wall to the lumen-intima and media-adventitia 
interfaces of the far wall.  Carotid intima-media thickness was the mean difference between 
these distances.  The carotid measurements were obtained over 3 separate intervals of 5.2 
s, which on average included 15 heart cycles.4   
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Other measurements  
At each contact, the nurses administered the same questionnaire to collect information about 
the participants’ medical history, smoking and drinking habits, and intake of medications.  
Body mass index was body weight in kilogram divided by body height in meter squared.  
Venous blood samples were drawn for measurement of serum total cholesterol and blood 
glucose.  Diabetes was the use of antidiabetic drugs, a fasting blood glucose concentration 
of at least 7.0 mmol/L,9 a random blood glucose concentration of at least 11.1 mmol/L,9 a 
self-reported diagnosis, or diabetes documented in practice or hospital records.   
Statistical analysis  
For database management and statistical analysis, we used SAS software (SAS Institute, 
Cary, NC), version 9.3.  We compared means and proportions, using a large sample z test, 
and 2 statistic, respectively.  We searched for possible covariables of the blood pressure 
measurements and arterial traits, using a stepwise regression procedure with P values for 
independent variables to enter and to stay in the model set at 0.15.  We used mixed models 
to study the association between the outcome and predictor variables, while adjusting for 
baseline characteristics, including sex, age, body mass index, heart rate, smoking and 
drinking, intake of female sex hormones, non-steroidal anti-inflammatory drugs and 
antihypertensive drugs, and serum cholesterol and blood glucose, and follow-up duration.  A 
sensitivity analysis additionally accounted for family clusters modeled as a random effect.  In 
the analysis of the BPART cohort, we adjusted blood pressure for the indexes of blood 
pressure variability and vice versa.   
We confined our analyses to systolic blood pressure, because it is the distending force 
and the major cardiovascular risk factor.  We assessed within-visit blood pressure variability 
from the variability independent of the mean,10 the difference between the maximum minus 
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minimum blood pressure,10 and average real variability.11  VIM is calculated as the SD 
divided by the mean to the power x and multiplied by the population mean to the power x.  
The power x is obtained by fitting a curve through a plot of SD against mean using the model 
SD = a  meanx,10 where x was derived by nonlinear regression analysis as implemented in 
the PROC NLIN procedure of the SAS package.  The values of x in BPART and ARTBP 
cohorts were 1.51 and 1.43, respectively.   Average real variability is the average of the 
absolute differences between consecutive blood pressure measurements,11 according to the 
formula  
1
1
1
1 n
k k
k
ARV BP BP



  n 1
 
,where  indicates the sum of the absolute differences between consecutive blood pressure 
(BP) readings, and k ranges from 1 to N-1.  In the current study, the number of blood 
pressure readings (N) was five.   
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Figure S1.  Flow chart of participants.   
BP→ART cohort and ART→BP cohort refer to participants analyzed to predict arterial 
properties at follow-up from blood pressure at baseline or participants analyzed to predict 
blood pressure at follow-up from arterial properties at baseline.  Abbreviations: cIMT, carotid 
intima-media thickness; cDC, carotid distensibility coefficient; cfPWV, carotid-femoral pulse 
wave velocity; BP, blood pressure.   
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Table S1.  Association of arterial phenotypes at follow-up with baseline characteristics in BPART cohort   
Regression parameters  
(approximate SD)  
 
Carotid  
intima-media thickness  
(m)  
Carotid  
distensibility  
(10-3/kPa)  
Carotid-femoral  
pulse wave velocity  
(m/s)  
R2   0.302  0.514  0.284  
Baseline characteristics      
Being female   … 1.69 (0.609 to 2.77)†  –0.228 (–0.443 to –0.012)*  
Age (+15 years)   73.0 (57.2 to 88.7)‡  –7.92 (–8.59 to –7.24)‡  1.03 (0.897 to 1.16)‡  
Body mass index (+4 kg/m
2
)   … –0.990 (–1.53 to –0.452)‡  0.165 (0.049 to 0.281)†  
Heart rate (+10 beats per minute)   36.5 (24.3 to 48.7)‡  –0.537 (–1.04 to –0.030)*  0.185 (0.074 to 0.296)†  
Antihypertensive drug treatment   …  …  0.700 (0.306 to 1.09)‡  
Drinking alcohol (0,1)    –34.3 (–60.2 to –8.43)†  … … 
Total cholesterol (+1 mmol/L)   22.4 (11.7 to 33.0)‡  –0.684 (–1.13 to –0.233)†  … 
Blood glucose (+1 mmol/L)   …  …  0.114 (0.014 to 0.213)*  
Carotid diameter (+1 mm)   64.2 (50.4 to 78.0)‡  …  …  
Effect sizes (95% confidence interval) express the change in the arterial properties associated with a 1-SD increase in the baseline variables.  R2 is the percentage of variance 
explained by the whole model.  Baseline characteristics considered for entry in the stepwise regression procedure included: sex, age, body mass index, intake of female sex 
hormones, non-steroidal anti-inflammatory drugs and antihypertensive drugs, serum cholesterol, blood glucose and follow-up duration.  For carotid intima-media thickness and 
distensibility, carotid diameter was also offered as a covariable.   
Significance of the estimates: * P<0.05; † P<0.01; ‡ P<0.001.   An ellipsis indicates that the variable did not enter the regression model.   
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Table S2.  Association of systolic indexes at follow-up with baseline characteristics in ARTBP cohort  
Regression parameters  
(approximate SD)  
 
Systolic pressure  
level  
(mm Hg)  
Variability independent  
of the mean  
(unit)  
Maximum-minimum  
difference  
(mm Hg)  
Average real variability  
(mm Hg)  
R2   0.445  0.026  0.067  0.056  
Age (+15 years)   3.21 (2.15 to 4.27)‡  … … … 
Body mass index (+4 kg/m2)   … –0.202 (–0.342 to –0.061)†  –0.572 (–0.970 to –0.175)†  –0.189 (–0.348 to –0.030)*  
Systolic pressure (+15 mm Hg)   8.07 (7.15 to 8.99)‡  … 0.838 (0.444 to 1.23)‡  0.330 (0.174 to 0.486)‡  
Antihypertensive drug treatment (0,1)   4.34 (1.66 to 7.02)†  0.430 (0.040 to 0.820)*  1.53 (0.395 to 2.66)†  0.506 (0.052 to 0.960)*  
Smoking (0,1)   2.47 (0.599 to 4.35)†  –0.350 (–0.641 to –0.059)*  …  …  
Blood glucose (+1 mmol/L)   …  …  …  0.192 (0.044 to 0.341)*  
Effect sizes (95% confidence interval) express the change in the systolic indexes associated with a 1-SD increase in the baseline variables.  R2 is the percentage of variance explained 
by the whole model.  Baseline characteristics considered for entry in the stepwise regression procedure included: sex, age, body mass index, intake of female sex hormones, non-
steroidal anti-inflammatory drugs and antihypertensive drugs, serum cholesterol, blood glucose and follow-up duration.   
Significance of the estimates: * P<0.05; † P<0.01; ‡ P<0.001.  An ellipsis indicates that the variable did not enter the regression model.   
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Table S3. Association of arterial phenotypes at follow-up with systolic predictors in the BPART cohort — analysis accounting for 
family clusters  
Predictor variable  
(approximate SD)   
 Model  
Carotid  
intima-media thickness  
(m)  
Carotid  
distensibility  
(10-3/kPa)  
Carotid-femoral  
pulse wave velocity  
(m/s)  
Systolic pressure (+15 mm Hg)   None   15.7 (2.93 to 28.6)*  –1.50 (–2.07 to –0.934)‡  0.285 (0.159 to 0.411)‡  
 VIM  15.3 (2.51 to 28.1)*  –1.49 (–2.06 to –0.926)‡  0.286 (0.161 to 0.412)‡  
 MMD  17.3 (4.15 to 30.4)*  –1.52 (–2.10 to –0.936)‡  0.275 (0.147 to 0.404)†  
 ARV  17.1 (4.04 to 30.1)*  –1.45 (–2.03 to –0.873)‡  0.277 (0.150 to 0.405)‡  
Variability independent of the 
mean (+2 units)  
 None  –8.65 (–19.8 to 2.49)  0.184 (–0.308 to 0.676)  0.016 (–0.092 to 0.124)  
 SBP  –8.05 (–19.2 to 3.08)  0.133 (–0.353 to 0.619)  0.027 (–0.080 to 0.134)  
Difference of maximum minus 
minimum systolic pressure  
(+5 mm Hg)   
 None  –2.84 (–13.4 to 7.69)  –0.201 (–0.665 to 0.264)  0.084 (–0.018 to 0.186)  
 SBP  –5.85 (–16.6 to 4.89)  0.061 (–0.408 to 0.530)  0.037 (–0.066 to 0.140)  
Average real variability 
(+2 mm Hg)  
 None  –3.57 (–13.7 to 6.56)  –0.427 (–0.873 to 0.018)  0.072 (–0.025 to 0.170)  
 SBP  –5.93 (–16.2 to 4.34)  –0.226 (–0.673 to 0.220)  0.035 (–0.063 to 0.133)  
Model indicates which systolic index was entered into the models in addition to the predictor variable per se: … no additional systolic index entered; VIM, 
variability independent of the mean; MMD, the difference of maximum minus minimum systolic blood pressure; ARV, average real variability; and SBP, level of 
systolic pressure.  Effect sizes (95% confidence interval) express the change in the arterial properties associated with a 1-SD increase in the systolic predictor.   
All models were adjusted for the covariables listed in Table S1 and account for family clusters.   
Significance of the estimates: * P<0.05; † P<0.01; ‡ P<0.001.  
Page 13 of 15  
 
Table S4.  Association of systolic indexes at follow-up with arterial predictors at baseline in ARTBP cohort — analysis accounting for family clusters   
Predictor variable  
(approximate SD)  
Systolic pressure  
(mm Hg)  
Variability independent  
of the mean  
(unit)  
Difference of maximum  
minus minimum pressure  
(mm Hg)  
Average real  
variability  
(mm Hg)  
Carotid intima-media thickness (+230 μm)  0.743 (–0.366 to 1.85)  0.166 (0.021 to 0.310)*   0.527 (0.062 to 0.991)*  0.179 (0.004 to 0.354)*  
Carotid distensibility ( +13 10-3/kPa)   –2.61 (–4.34 to –0.884)†  –0.516 (–0.778 to –0.254)‡  –1.71 (–2.41 to –1.01)‡  –0.614 (–0.896 to –0.331)‡  
Carotid-femoral pulse wave velocity (+2 m/s)   1.07 (0.070 to 2.07)*  –0.127 (–0.280 to 0.025)  –0.162 (–0.572 to 0.247)  –0.084 (–0.249 to 0.081)  
Effect sizes (95% confidence interval) express the systolic indexes associated with a 1-SD increase in the arterial predictor.   All models were adjusted for the covariables listed in Table S2 
and accounted for family clusters.   
Significance of the estimates: * P<0.05; † P<0.01; ‡ P<0.001.    
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Table S5. Association of arterial phenotypes at follow-up with systolic predictors in the BPART Cohort — analysis accounting for 
family clusters (n=713)  
Predictor variable  
(approximate SD)   
 Model  
Carotid  
intima-media thickness  
(m)  
Carotid  
distensibility  
(10-3/kPa)  
Carotid-femoral  
pulse wave velocity  
(m/s)  
Systolic pressure (+15 mm Hg)   None   15.2 (0.349 to 30.1)*  –1.41 (–2.00 to –0.812)*  0.194 (0.039 to 0.350)‡  
 VIM  14.9 (0.077 to 29.7)*  –1.40 (–2.00 to –0.809)*  0.194 (0.039 to 0.350)‡  
 MMD  19.1 (3.79 to 34.4)*  –1.53 (–2.15 to –0.920)*  0.173 (0.011 to 0.334)†  
 ARV  17.9 (2.69 to 33.1)*  –1.43 (–2.04 to –0.818)*  0.180 (0.021 to 0.340)‡  
Variability independent of the 
mean (+2 units)  
 None  –14.7 (–29.8 to 0.352)  0.527 (–0.257 to 0.173)  0.042 (–0.088 to 0.173)  
 SBP  –14.5 (–29.3 to 0.318)  0.516 (–0.270 to 0.172)  0.042 (–0.088 to 0.172)  
Difference of maximum minus 
minimum systolic pressure  
(+5 mm Hg)   
 None  –8.72 (–20.6 to 3.19)  0.089 (–0.388 to 0.222)  0.100 (–0.022 to 0.222)  
 SBP  –12.5 (–25.3 to 0.205)  0.395 (–0.090 to 0.191)  0.065 (–0.061 to 0.191)  
Average real variability 
(+2 mm Hg)  
 None  –6.72 (–17.8 to 4.41)  –0.152 (–0.596 to 0.189)  0.075 (–0.039 to 0.189)  
 SBP  –9.52 (–20.8 to 1.82)  0.075 (–0.411 to 0.162)  0.046 (–0.070 to 0.162)  
Model indicates which systolic index was entered into the models in addition to the predictor variable per se: … no additional systolic index entered; VIM, 
variability independent of the mean; MMD, the difference of maximum minus minimum systolic blood pressure; ARV, average real variability; and SBP, level of 
systolic pressure.  Effect sizes (95% confidence interval) express the change in the arterial properties associated with a 1-SD increase in the systolic predictor.   
All models were adjusted for the covariables listed in Table S1 and account for family clusters.   
Significance of the estimates: * P<0.05; † P<0.01; ‡ P<0.001.  
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Table S6.  Characteristics of participants returning or not for arterial phenotyping   
Characteristic  Returning  Not returning  P   
Number of subjects   1379  1905     
Number (%) with characteristic       
Women   708 (51.3)  961 (50.5) 0.62  
Smoking   470 (34.1)  432 (22.7)  <0.0001  
Drinking   392 (28.4)  606 (31.8)  0.037  
Hypertension    425 (30.8)  619 (32.5)  0.32  
Antihypertensive treatment   251 (18.2)  324 (17.2)  0.37  
Use of female hormones   178 (12.9)  218 (11.4) 0.21  
Use of NSAID    108 (7.83)  148 (7.80)  0.95  
Diabetes mellitus   42 (3.04)  74 (3.88)  0.21  
Mean (±SD) characteristic       
Age, years   47.4±16.8  45.3±19.6  <0.0001  
Body mass index, kg/m2    25.7±4.6  25.4±4.7  0.10  
Total cholesterol, mmol/L   5.43±1.06  5.33±1.19  <0.0001  
Blood glucose, mmol/L   5.28±1.56  5.24±1.54  0.72  
Diastolic pressure, mm Hg   75.8±10.4 75.2±10.6 0.30  
Systolic pressure       
Level, mm Hg   124.1±15.7 125.6±17.3 0.0002  
VIM, mm Hg   3.43±1.85 3.56±1.92 0.14  
MMD, mm Hg   8.37±5.01 8.67±5.16 0.23  
ARV, mm Hg   3.59±2.08 3.73±2.22 0.007  
Heart rate, beats per minute   67.2±8.5 69.7±9.6 <0.0001  
NSAID indicate interquartile range and non-steroidal anti-inflammatory drugs, respectively.  To convert 
cholesterol and glucose from mmol/L to mg/dL, multiply by 38.6 and 18.0, respectively.  Blood pressure was 
the average of five consecutive readings at a single visit.  Abbreviations: VIM, variability independent of the 
mean; MMD; difference of maximum minus minimum blood pressure; ARV, average real variability.   
Significance of the difference: * P0.05; † P0.01; ‡ P0.001.   
 
